EUR 1.47
(8.09%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -2.34 Million EUR | -73.68% |
2022 | -1.35 Million EUR | -93.97% |
2021 | -483.65 Thousand EUR | -519.63% |
2020 | - EUR | 37.54% |
2019 | -180.04 Thousand EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -1.33 Million EUR | 0.0% |
2023 Q2 | -426.76 Thousand EUR | 19.18% |
2023 FY | - EUR | 16.84% |
2023 Q3 | -645.73 Thousand EUR | -51.31% |
2023 Q1 | -528.03 Thousand EUR | 51.69% |
2023 Q4 | -645.73 Thousand EUR | 0.0% |
2022 Q3 | -859.69 Thousand EUR | -49.01% |
2022 Q2 | -576.92 Thousand EUR | -14.24% |
2022 Q1 | -505 Thousand EUR | -96.84% |
2022 FY | - EUR | -93.97% |
2022 Q4 | -1.09 Million EUR | -27.15% |
2021 FY | - EUR | -519.63% |
2021 Q1 | -102.73 Thousand EUR | 75.93% |
2021 Q4 | -256.55 Thousand EUR | -43.45% |
2021 Q3 | -178.84 Thousand EUR | -2.64% |
2021 Q2 | -174.25 Thousand EUR | -69.62% |
2020 Q1 | 94.2 Thousand EUR | 0.0% |
2020 Q4 | -426.72 Thousand EUR | -5339.13% |
2020 FY | - EUR | 37.54% |
2020 Q3 | 8145.00 EUR | -91.35% |
2020 Q2 | 94.2 Thousand EUR | 0.0% |
2019 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Affluent Medical SA | -13.34 Million EUR | 82.406% |
Bluelinea Société Anonyme | -323.98 EUR | -724489.789% |
Carmat SA | -50.45 Million EUR | 95.347% |
Diagnostic Medical Systems S.A. | -7.05 Million EUR | 66.735% |
Euromedis Groupe | -4.43 Million EUR | 47.07% |
Eurobio Scientific Société anonyme | 18.98 Million EUR | 112.365% |
Implanet S.A. | -5.07 Million EUR | 53.762% |
Median Technologies SA | -19.58 Million EUR | 88.014% |
SpineGuard SA | -3.49 Million EUR | 32.867% |
Theraclion SA | -4.48 Million EUR | 47.684% |
Euroapi S.A. | -155.39 Million EUR | 98.489% |
Guerbet SA | 98.83 Million EUR | 102.375% |
Ion Beam Applications SA | 12.53 Million EUR | 118.735% |
Koninklijke Philips N.V. | 1.04 Billion EUR | 100.226% |
Sequana Medical NV | -29.13 Million EUR | 91.943% |